Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.56 |
| ▸ | F7 | P08709 | 6/20 | 0.56 |
| ▸ | F3 | P13726 | 6/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.56 |
| ▸ | PPARG | P37231 | 5/20 | 0.56 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.56 |
| ▸ | PPARD | Q03181 | 4/20 | 0.56 |
| ▸ | PPARA | Q07869 | 4/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3742738 | 1.00 | MAPT (0.60) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL3742740 | 1.00 | MAPT (0.60) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL6244558 | 0.96 | MAPT (0.54) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL653863 | 0.94 | MAPT (0.63) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL3742728 | 0.91 | MAPT (0.50) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL17547609 | 0.91 | MAPT (0.50) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL3746335 | 0.90 | MAPT (0.54) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL17547604 | 0.90 | MAPT (0.54) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL13442941 | 0.89 | CNR1 (0.50) | MAPTALDH1A1F7F3CYP19A1 | |
| SCHEMBL3735864 | 0.89 | MAPT (0.72) | MAPTALDH1A1F7F3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250216407-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. | 2025-07-03 | — | — | US | claimed |
| WO-2023192314-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. (US) | 2023-10-05 | — | — | WO | claimed |
| WO-2025227044-A1 | BIOACTIVE LIPIDS, SYSTEMS AND METHODS OF OBTAINING BIOACTIVE LIPIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-30 | — | — | WO | disclosed |
| US-20250216407-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. | 2025-07-03 | — | — | US | disclosed |
| EP-3335140-B1 | SYSTEMS, APPARATUS, AND METHODS FOR ANALYZING AND PREDICTING CELLULAR PATHWAYS | MASSACHUSETTS INST TECHNOLOGY (US) | 2025-02-19 | — | — | EP | disclosed |
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | KADDURAH DAOUK RIMA F (US) | 2023-11-23 | — | — | US | disclosed |
| WO-2023192314-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2016033605-A1 | IMPROVED ASPHALT PRODUCTS AND MATERIALS AND METHODS OF PRODUCING THEM | IOWA STATE UNIVERSITY RESEARCH FOUNDATION INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| US-9149019-B2 | Method of eliminating cat urine odor | JMR, LC (US) | 2015-10-06 | — | — | US | disclosed |
| US-20130323194-A1 | METHOD OF ELIMINATING CAT URINE ODOR | CO2 TECHNOLOGIES, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| US-20070066170-A1 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2007-03-22 | — | — | US | disclosed |
| US-7189666-B2 | CO2 generating absorbent pads | CO2 TECHNOLOGIES (US) | 2007-03-13 | — | — | US | disclosed |
| US-7160939-B2 | Preservatives; mixture of carbon dioxide in polymer matrix; mixture containing citric acid, calcium carbonate and low density polyethylene | CO2 TECHNOLOGIES, INC. | 2007-01-09 | — | — | US | disclosed |
| WO-2005005520-A2 | ACTIVE MASTERBATCH FOR PRODUCTION OF CO2 GENERATING MASTERBATCH | CO2 TECHNOLOGIES, INC. (US) | 2005-01-20 | — | — | WO | disclosed |
| US-20050001204-A1 | Active masterbatch for production of CO2 generating masterbatch | CO2 TECHNOLOGIES, INC. (US) | 2005-01-06 | — | — | US | disclosed |
| WO-2004110876-A2 | CO2 GENERATING ABSORBENT PADS | CO2 TECHNOLOGIES, INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| US-20040247750-A1 | CO2 generating absorbent pads | CO2 TECHNOLOGIES, INC. | 2004-12-09 | — | — | US | disclosed |
| US-6797235-B2 | Device and methods for modifying an atmosphere | CO2 TECHNOLOGIES, INC. | 2004-09-28 | — | — | US | disclosed |
| WO-2004022112-A1 | DEVICE AND METHODS FOR MODIFYING AN ATMOSPHERE | CO2 TECHNOLOGIES, INC. (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20040047760-A1 | Device and methods for modifying an atmosphere | LONGER SHELF LIFE, LLC | 2004-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230375561-A1 | METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES | SLC25A20, CPT2, NDUFAB1 | MAPT 1858/4885ALDH1A1 476/4885F7 4849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.